Pacira Pharmaceuticals Financial Overview
Pacira Pharmaceuticals's market cap is currently $1.14B. The company's EPS TTM is $0.7; its P/E ratio is 58.01; Pacira Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.90. See an overview of income statement, balance sheet, and cash flow financials.
